Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Ryan, Wilcox"'
Autor:
Carlos Murga-Zamalloa, Shaun Webb, John Reneau, Alejandro Zevallos, Pierina Danos-Diaz, Vanessa Perez-Silos, Mirna Rodriguez, Guangyao Gao, Wolf-Nicolas Fischer, Bernd Jandeleit, Ryan Wilcox
Publikováno v:
Leukemia Research Reports, Vol 21, Iss , Pp 100398- (2024)
T-cell lymphomas are aggressive neoplasms characterized by poor responses to current chemotherapeutic agents. Expression of the l-type amino acid transporter 1 (LAT 1, SLC7A5) allows for the expansion of healthy T-cell counterparts, and upregulation
Externí odkaz:
https://doaj.org/article/8998a2e3b96f4b23b775c3aba7f40590
Autor:
Yuka Torii, Kana Nanjo, Tomomi Toubai, Masashi Hosokawa, Ryo Sato, Akane Yamada, Keiko Aizawa, Masahito Himuro, Satoshi Ito, Masakazu Yamamoto, John Magenau, Ryan Wilcox, Kenichi Ishizawa
Publikováno v:
Journal of Medical Case Reports, Vol 15, Iss 1, Pp 1-6 (2021)
Abstract Background Chronic myeloid leukemia is a hematologic malignancy associated with the fusion of two genes: BCR and ABL1. This fusion results from a translocation between chromosomes 9 and 22, which is called the Philadelphia chromosome. Althou
Externí odkaz:
https://doaj.org/article/96e8a34788454a97baa4b4773d89fcf7
Autor:
Taylor Novice, BS, Ji Won Ahn, MD, Ryan Wilcox, MD, PHD, Trilokraj Tejasvi, MBBS, Alexandra Hristov, MD, Jennifer Mancuso, MD
Publikováno v:
JAAD Case Reports, Vol 6, Iss 4, Pp 311-315 (2020)
Externí odkaz:
https://doaj.org/article/c5673d3ffccc4b459ba95f8df0253dbb
Autor:
Yuka Torii, Kana Nanjo, Tomomi Toubai, Masashi Hosokawa, Ryo Sato, Akane Yamada, Keiko Aizawa, Masahito Himuro, Satoshi Ito, Masakazu Yamamoto, John Magenau, Ryan Wilcox, Kenichi Ishizawa
Publikováno v:
Kompass Onkologie. 10:46-49
Hintergrund: Die chronische myeloische Leukämie ist eine hämatologische Malignität, die mit der Fusion von zwei Genen einhergeht: BCR und ABL1. Diese Fusion resultiert aus einer Translokation zwischen den Chromosomen 9 und 22, auch als Philadelphi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::25d22d7da91c61171c52162ae464161d
https://doi.org/10.1159/000529714
https://doi.org/10.1159/000529714
Autor:
Steven M. Horwitz, Stephen Ansell, Weiyun Z. Ai, Jeffrey Barnes, Stefan K. Barta, Jonathan Brammer, Mark W. Clemens, Ahmet Dogan, Francine Foss, Paola Ghione, Aaron M. Goodman, Joan Guitart, Ahmad Halwani, Bradley M. Haverkos, Richard T. Hoppe, Eric Jacobsen, Deepa Jagadeesh, Allison Jones, Avyakta Kallam, Youn H. Kim, Kiran Kumar, Neha Mehta-Shah, Elise A. Olsen, Saurabh A. Rajguru, Sima Rozati, Jonathan Said, Aaron Shaver, Lauren Shea, Michi M. Shinohara, Lubomir Sokol, Carlos Torres-Cabala, Ryan Wilcox, Peggy Wu, Jasmine Zain, Mary Dwyer, Hema Sundar
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:285-308
Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of lymphoproliferative disorders arising from mature T cells, accounting for about 10% of non-Hodgkin lymphomas. PTCL-not otherwise specified is the most common subtype, followed by angioi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78e3cd2682863473cc16c884b359a24e
https://doi.org/10.6004/jnccn.2022.0015
https://doi.org/10.6004/jnccn.2022.0015
Autor:
Ryan Wilcox
Publikováno v:
Journal of Agricultural and Environmental Ethics. 35
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1db87e6648b7abfa0937ca3230c9002c
https://doi.org/10.1007/s10806-022-09885-4
https://doi.org/10.1007/s10806-022-09885-4
Autor:
Adam L Cohen, Raffaella Soldi, Haiyu Zhang, Adam M Gustafson, Ryan Wilcox, Bryan E Welm, Jeffrey T Chang, Evan Johnson, Avrum Spira, Stefanie S Jeffrey, Andrea H Bild
Publikováno v:
Molecular Systems Biology, Vol 7, Iss 1, Pp 1-13 (2011)
Abstract Identifying the best drug for each cancer patient requires an efficient individualized strategy. We present MATCH (Merging genomic and pharmacologic Analyses for Therapy CHoice), an approach using public genomic resources and drug testing of
Externí odkaz:
https://doaj.org/article/1741f4b3bdb943c39a39dfea025050ae
Autor:
Jennifer, Girard, Yasmin, Karimi, Shannon, Carty, Ryan, Wilcox, Mark, Kaminiski, Sami, Malek, Tycel, Phillips
Publikováno v:
Current hematologic malignancy reportsPapers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance. 16(1)
Follicular lymphoma (FL) is the 2nd most common lymphoma in the USA/Western Europe. While incurable, the majority of patients are able to survive at least a decade with this disease. Response duration though varies, and subset of patients will relaps
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1a35c3488026d99ac7611d6d7a71732d
https://pubmed.ncbi.nlm.nih.gov/33754292
https://pubmed.ncbi.nlm.nih.gov/33754292
Autor:
Neha, Mehta-Shah, Steven M, Horwitz, Stephen, Ansell, Weiyun Z, Ai, Jeffrey, Barnes, Stefan K, Barta, Mark W, Clemens, Ahmet, Dogan, Kristopher, Fisher, Aaron M, Goodman, Gaurav, Goyal, Joan, Guitart, Ahmad, Halwani, Bradley M, Haverkos, Richard T, Hoppe, Eric, Jacobsen, Deepa, Jagadeesh, Matthew A, Lunning, Amitkumar, Mehta, Elise A, Olsen, Barbara, Pro, Saurabh A, Rajguru, Satish, Shanbhag, Aaron, Shaver, Andrei, Shustov, Lubomir, Sokol, Pallawi, Torka, Carlos, Torres-Cabala, Ryan, Wilcox, Basem M, William, Jasmine, Zain, Mary A, Dwyer, Hema, Sundar, Youn H, Kim
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN. 18(5)
Mycosis fungoides (MF) is the most common subtype of cutaneous T-cell lymphoma (CTCL), and Sézary syndrome (SS) is a rare erythrodermic and leukemic subtype of CTCL characterized by significant blood involvement. Although early-stage disease can be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0939b30a42c78a3ecb3f08f30c2524d0
https://pubmed.ncbi.nlm.nih.gov/32380458
https://pubmed.ncbi.nlm.nih.gov/32380458
Autor:
Youn H. Kim, Martine Bagot, Pier Luigi Zinzani, Madeleine Duvic, Stephen Morris, Ellen Kim, Amy Musiek, Pablo L. Ortiz-Romero, Craig Elmets, Herbert A. Eradat, Nina Magnolo, Julia Scarisbrick, Stéphane Dalle, David C. Fisher, Michi Shinohara, Brian Poligone, Barbara Pro, Pietro Quaglino, Nishitha Reddy, Brigitte Dreno, Larisa J Geskin, Ahmad S Halwani, Amit Khot, Marie Beylot-Barry, Neil Korman, Frederick Lansigan, Steven M. Horwitz, Zanetta S. Lamar, Alison J. Moskowitz, Jillian Wells, Oleg E. Akilov, Dolores Caballero, Richard Cowan, Reinhard Dummer, Mary Jo Lechowicz, Francine M. Foss, Lars Iversen, Tomomitsu Miyagaki, Ryan Wilcox, Pierluigi Porcu, Maarten Vermeer, Sunil Abhyankar, Yukihiko Kato, Theresa Pacheco, Shigetoshi Sano, Basem M. William, Timothy S. Fenske, Noriko Fukuhara, Koji Habe, Toshihisa Hamada, Eiji Kiyohara, Bryone J. Kuss, Adam Lerner, Lawrence Mark, Javier Munoz, Hiroyuki Okamoto, Christiane Querfeld, Jiro Uehara, Hisashi Uhara, Kentaro Yonekura, Auris Huen, Kensei Tobinai, Yoshiki Tokura, Erin Boh, Jan Nicolay, Hidefumi Wada, Mollie Leoni, Takahiro Ito, Fiona Herr, Lubomir Sokol
Publikováno v:
Blood. 134:5300-5300
Introduction: MAVORIC was an open-label, multicenter, randomized phase 3 study evaluating the safety and efficacy of mogamulizumab (moga) compared to vorinostat (vori) in patients with mycosis fungoides (MF) or Sézary syndrome (SS) who had failed at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c51d9bc27e6a104d6dc1b97fec00a23e
https://doi.org/10.1182/blood-2019-122778
https://doi.org/10.1182/blood-2019-122778